Plate blue root particles, Nofluorosacin capsules, such as a number of common drugs were found to be unqualified

On November 28, the Guangdong Provincial Drug Administration issued the Notice noisy noday 8 of 2019 on drug spot-checking information, announcing that 19 batches of drugs were not tested, involving 14 pharmaceutical manufacturers's Circular shows that in order to strengthen drug quality supervision and ensure the safety of drug use by the public, the Guangdong Provincial Drug Administration has organized a spot check on drug quality in the province's drug production, operating enterprises and medical institutions in accordance with the 2019 Guangdong Province Drug Sampling Planverified and confirmed that a total of 19 varieties of 19 batches of drugs in the current period after inspection did not meet the standard series, of which, the circulation link detected 12 batches, the use of the link to detect 7 batchesmainly does not meet the prescribed items have characteristics, load differences, disintegrating time limit, moisture, solubility, related substances, particle size, content determination and so onat present, the Guangdong Provincial Drug Administration has instructed the relevant municipal market supervision bureau to take the necessary control measures such as seizure, seizure, suspension of sales and recall of unqualified drugs, investigate and punish the production enterprises and the units under sampling in accordance with relevant laws and regulations, and continue to follow up spot checks on these drugsin the circulation of the drug list does not meet the provisionsin the use of the link sampling of drugs that do not meet the requirements of the list